1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation
  4. >>Regulation

Rx-To-OTC Switch And RWE Key To Creating ‘Crisis Proof’ European Medicines System

 
• By David Ridley

Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy. 

3d render of Europe map Earth globe
• Source: Shutterstock

The Association of the European Self-Care Industry, AESGP, is urging the European Commission to use its new pharmaceutical strategy to widen access to OTC medicines in the region.

Rx-to-OTC switch and real-world evidence are two ways that the Commission can make pharmaceutical regulation “smarter,” the AESGP argues in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

Norway Decides Against Tighter Restrictions For Ibuprofen

 
• By Tom Gallen

Norway's Medical Products Agency has rejected claims that misuse of OTC ibuprofen is linked to its availability for purchase in outlets other than pharmacies.

Latest OTC Eye Drop Production Problem In US Prompts Firm To Close Doors After Recalls

 
• By Malcolm Spicer

BRS Analytical Services in St. Louis recalled more than 75,000 cases of redness and lubricating eye drops and committed “to permanently cease production of all drugs.”

US FDA Plans Move Inspectorate Back To More Generalist Organization

 
• By Sarah Karlin-Smith and Derrick Gingery

The “Simple Reform” initiative would reverse a 2017 move to ensure FDA investigators were experts in the commodity they inspected or in clinical research regulations.

RFK Jr. Ally Authors Citizen Petition For Label Warnings Of Prenatal Acetaminophen Exposure

 
• By Malcolm Spicer

Informed Consent Action Network requests warning on acetaminophen-containing OTC monograph drugs in petition submitted by Siri & Glimstad LLP, where partner Aaron Siri has provided legal counsel for HHS Secretary Kennedy. Tylenol marketer Kenvue disputes ICAN’s conclusions and its grasp of FDA regul

More from Policy & Regulation

GSCF: Self-Care Key To UN’s Noncommunicable Disease Aims

 
• By David Ridley

The United for Self-Care Coalition publishes a manifesto that it hopes will accelerate the UN’s vision set out in a recent political declaration that aims to prevent and control non-communicable diseases and promote mental health and wellbeing.

Texas Waves ‘MAHA’ Flag With Complaint Alleging Autism Link To Prenatal Acetaminophen Exposure

 
• By Malcolm Spicer

In addition to Kenvue, complaint names as defendant J&J, which for decades marketed Tylenol oral analgesics before spinning Kenvue out in 2023. State asks court to order firms to pay $10,000 for each violation of state Deceptive Trade Practices-Consumer Protection Act.

Latest OTC Eye Drop Production Problem In US Prompts Firm To Close Doors After Recalls

 
• By Malcolm Spicer

BRS Analytical Services in St. Louis recalled more than 75,000 cases of redness and lubricating eye drops and committed “to permanently cease production of all drugs.”